Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
4.970
-0.010 (-0.20%)
Sep 26, 2025, 4:00 PM EDT - Market closed

Serina Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
5147---
Enterprise Value
4555---
Last Close Price
4.975.01---
PS Ratio
391.89840.25---
PB Ratio
30.9592.63---
P/TBV Ratio
-73.41---
EV/Sales Ratio
348.20990.71---
Debt / Equity Ratio
0.220.910.90-0.771.19
Asset Turnover
0.010.010.640.44-
Quick Ratio
1.701.555.391.223.53
Current Ratio
2.242.405.391.253.58
Return on Equity (ROE)
--485.36%594.25%--
Return on Assets (ROA)
-132.37%-124.04%-19.46%-105.01%-
Return on Capital (ROIC)
--221.85%-26.28%-1390.61%-
Earnings Yield
-24.94%-23.68%---
FCF Yield
-30.77%-36.47%---
Buyback Yield / Dilution
-138.29%-0.11%-242.70%-0.01%-
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q